Keyword: University of California San Francisco
The Weill Family Foundation is stumping up $106 million to create a so-called “Neurohub.”
The consortium intends to make new tools, models and processes broadly available, with a large focus on solutions geared toward cancer patients.
Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.
Encellin is working on a cell pouch that cuts down on the scarring that comes with encapsulated cell transplants.
GlaxoSmithKline is joining forces with the University of California to dig into how gene mutations cause disease and use CRISPR to discover new drugs.
Tmunity Therapeutics has licensed a T-cell receptor treatment from UCSF and aims to start human trials by 2021.
Researchers at the University of Toronto and UCSF point to the gut as the source of immune cells that mitigate brain inflammation in MS.
Using a deep learning algorithm and PET images of the brain, researchers trained an AI to spot Alzheimer’s over 6 years ahead of a clinical diagnosis.
Akili Interactive licensed new software from UCSF that combines physical activity with programs targeting neural systems to cognitive function.
James Pennington joined AzurRx BioPharma as CMO as the company aims to launch a phase 2 trial of its lead candidate in cystic fibrosis this year.